RUPOLI, SERENA
RUPOLI, SERENA
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience
2021-01-01 Rupoli, S.; Fiorentini, A.; Morsia, E.; Svegliati-Baroni, G.; Micucci, G.; Maroni, L.; Garvey, K. B.; Fiorentini snr, A.; Riva snr, A.; Da Lio, L.; Benedetti, A.; Offidani, M.; Olivieri, A.; Tarantino, G.
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas
2022-01-01 Uccella, S; Goteri, G; Maiorana, A; Donati, V; Tibiletti, Mg; Magnoli, F; Facchi, S; Merchiori, D; Morsia, E; Papotti, R; Bettelli, S; Forti, E; Galimberti, S; Rupoli, S; Filosa, A; Dardanis, D; Braglia, L; Pozzi, S; Sacchi, S
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas
2023-01-01 Uccella, Silvia; Goteri, Gaia; Maiorana, Antonino; Donati, Valentina; Tibiletti, Maria Grazia; Magnoli, Francesca; Facchi, Sofia; Merchiori, Deborah; Morsia, Erika; Papotti, Robel; Bettelli, Stefania; Forti, Elisa; Galimberti, Sara; Rupoli, Serena; Filosa, Alessandra; Dardanis, Dimitri; Bomben, Riccardo; Braglia, Luca; Pozzi, Samantha; Sacchi, Stefano
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
2024-01-01 Morsia, Erika; Torre, Elena; Martini, Francesco; More', Sonia; Poloni, Antonella; Olivieri, Attilio; Rupoli, Serena
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis
2022-01-01 Morsia, E; Torre, E; Marrara, F; More', S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report
2024-01-01 Manieri, Valentina Maria; Offidani, Massimo; Capelli, Debora; Marzioni, Marco; Maroni, Luca; Filosa, Alessandra; Rupoli, Serena; Morsia, Erika; Poloni, Antonella; Morè, Sonia
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma
2021-01-01 Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
2022-01-01 Morsia, E.; Torre, E.; Poloni, A.; Olivieri, A.; Rupoli, S.
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS?
2022-01-01 Morsia, E.; Torre, E.; Tarantino, G.; Svegliati Baroni, G.; Goteri, G.; Mancini, S.; Tassoni, A.; Alessandro, F.; Olivieri, A.; Rupoli, S.
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study
2022-01-01 Offidani, M; Zizzo, C; Rupoli, S; Federici, I; More', S; Bossi, A; Manieri, Vm; Petrucci, Mt; Di Toritto, Tc; Brunori, M; Gozzetti, A; Tordi, A; Fazio, F; Lisi, C; Melaccio, A; Ciuffreda, L; Falcone, Ap; Fioritoni, F; Gentili, S; Siniscalchi, A; Trastulli, F; Corvatta, L; Morsia, E; Olivieri, A; Duro, G
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints
2022-01-01 Rupoli, Serena; Goteri, Gaia; Morsia, Erika; Torre, Elena; Giantomassi, Federica; Campanati, Anna; Offidani, Anna Maria; Molinelli, Elisa; Brandozzi, Giuliano; Serresi, Stefano; Giacchetti, Alfredo; Bugatti, Leonardo; Filosa, Giorgio; Mozzicafreddo, Giorgio; Simonacci, Marco; Olivieri, Attilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience | 1-gen-2021 | Rupoli, S.; Fiorentini, A.; Morsia, E.; Svegliati-Baroni, G.; Micucci, G.; Maroni, L.; Garvey, K. B.; Fiorentini snr, A.; Riva snr, A.; Da Lio, L.; Benedetti, A.; Offidani, M.; Olivieri, A.; Tarantino, G. | |
| Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas | 1-gen-2022 | Uccella, S; Goteri, G; Maiorana, A; Donati, V; Tibiletti, Mg; Magnoli, F; Facchi, S; Merchiori, D; Morsia, E; Papotti, R; Bettelli, S; Forti, E; Galimberti, S; Rupoli, S; Filosa, A; Dardanis, D; Braglia, L; Pozzi, S; Sacchi, S | |
| Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas | 1-gen-2023 | Uccella, Silvia; Goteri, Gaia; Maiorana, Antonino; Donati, Valentina; Tibiletti, Maria Grazia; Magnoli, Francesca; Facchi, Sofia; Merchiori, Deborah; Morsia, Erika; Papotti, Robel; Bettelli, Stefania; Forti, Elisa; Galimberti, Sara; Rupoli, Serena; Filosa, Alessandra; Dardanis, Dimitri; Bomben, Riccardo; Braglia, Luca; Pozzi, Samantha; Sacchi, Stefano | |
| Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights | 1-gen-2024 | Morsia, Erika; Torre, Elena; Martini, Francesco; More', Sonia; Poloni, Antonella; Olivieri, Attilio; Rupoli, Serena | |
| Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis | 1-gen-2022 | Morsia, E; Torre, E; Marrara, F; More', S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S | |
| Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report | 1-gen-2024 | Manieri, Valentina Maria; Offidani, Massimo; Capelli, Debora; Marzioni, Marco; Maroni, Luca; Filosa, Alessandra; Rupoli, Serena; Morsia, Erika; Poloni, Antonella; Morè, Sonia | |
| Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma | 1-gen-2021 | Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A | |
| Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications | 1-gen-2022 | Morsia, E.; Torre, E.; Poloni, A.; Olivieri, A.; Rupoli, S. | |
| P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? | 1-gen-2022 | Morsia, E.; Torre, E.; Tarantino, G.; Svegliati Baroni, G.; Goteri, G.; Mancini, S.; Tassoni, A.; Alessandro, F.; Olivieri, A.; Rupoli, S. | |
| Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study | 1-gen-2022 | Offidani, M; Zizzo, C; Rupoli, S; Federici, I; More', S; Bossi, A; Manieri, Vm; Petrucci, Mt; Di Toritto, Tc; Brunori, M; Gozzetti, A; Tordi, A; Fazio, F; Lisi, C; Melaccio, A; Ciuffreda, L; Falcone, Ap; Fioritoni, F; Gentili, S; Siniscalchi, A; Trastulli, F; Corvatta, L; Morsia, E; Olivieri, A; Duro, G | |
| Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints | 1-gen-2022 | Rupoli, Serena; Goteri, Gaia; Morsia, Erika; Torre, Elena; Giantomassi, Federica; Campanati, Anna; Offidani, Anna Maria; Molinelli, Elisa; Brandozzi, Giuliano; Serresi, Stefano; Giacchetti, Alfredo; Bugatti, Leonardo; Filosa, Giorgio; Mozzicafreddo, Giorgio; Simonacci, Marco; Olivieri, Attilio |